Eagle, Idaho, May 08, 2017 -- Today, Advecta announced the launch of Advecta3, a new to market flea and tick treatment for dogs with the same active ingredients used in K9 Advantix II that sells at a fraction of the price at Walmart.
|
|||
“We are dedicated to providing traditional retailers and their customers with the same breadth of quality products that veterinarians recommend at their clinics, but at prices shoppers can afford,” said Cord Christensen, CEO of PetIQ, the parent company of Advecta. “We believe that quality flea and tick treatment should be widely available—not just to the privileged few. We’re proud to partner with major retailers to provide Advecta3 at an incredible value.”
Advecta3 is a monthly spot on treatment and preventative for fleas, ticks, biting flies, mosquitos, and lice. The waterproof product is sold as a 4-month supply. Advecta3 joins PetIQ’s lineup of quality Advecta flea and tick treatments which include sprays, shampoos, and spot on treatments.
Advecta3 for Dogs (MSRP: $32.99 for 4-month supply)
- Contains the same active ingredients used in K9 Advantix II
- Repels and kills ticks, fleas, and mosquitos
- Prevents development of fleas, flea eggs, and larvae
- Kills biting lice
- Kills fleas on dogs within 12 hours
- Waterproof and fragrance free
Every pet’s circumstances and living environment is different. That’s why Advecta provides a line of quality products, including shampoos, indoor sprays and yard sprays to help rid a pet and a pet’s environment of pesky critters.
- Advecta Flea and Tick Dog Shampoo kills fleas and ticks on contact; leaves no sticky residue
- Advecta Flea and Tick Spray for Dogs kills fleas and ticks on contact and will keep killing for up to 14 days on dogs.
- Advecta Indoor Spray for Fleas, Ticks, and Spiders Ready-to-Use Indoor Spray kills home invading pests on contact.
- Advecta Yard for Fleas, Ticks and Mosquitos – Yard Spray Concentrate kills on contact and keeps killing for up to four weeks.
About Advecta
Understanding the health risks associated with fleas is very important in order to ensure that each dog and cat is safe all season long. The mission of Advecta is to keep your pet healthy by providing a fast-acting and long lasting solution to treat and protect your pet from pests like fleas, flea eggs and larvae, and chewing lice. Advecta products are available at Walmart, Target and Menards retailers nationwide. More information can be found at www.advecta3.com.
*Advecta3 is not manufactured by or distributed by Bayer Healthcare LLC. K9 Advantix is a registered trademark of Bayer Healthcare LLC.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a6f6f07b-888f-4226-b0e5-cc7aa33f490b
Brianna Griff Pet IQ (formally True Science) 208-939-8900 x333 [email protected]


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Instagram Outage Disrupts Thousands of U.S. Users
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 



